than patients without a shock, but this effect did not differ between treatment arms. Randomized data of the subcutaneous implantable cardioverter-defibrillator and transvenous implantable ...

was developed to overcome the risk of lead-related complications associated with the transvenous implantable cardioverter-defibrillator (TV-ICD). In contrast to the TV-ICD, the S-ICD is a completely ...

In this prospective study, the use of a leadless pacemaker that received wireless communication from a subcutaneous ...

Transvenous embolization has emerged as a reliable treatment option. We review the clinical presentation, imaging, and clinical outcomes of 100 consecutive CSFVF patients who underwent embolization ...

Dr. Chandy John, left, assists a study medical officer in examining the retina of a child with cerebral malaria. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news ...

Patient flow forecasting is a fundamental tool in healthcare and pharmaceutical industries, enabling stakeholders to predict and plan for the treatment requirements of patients accurately.

Shocking-pathway impedance normally is 25–75 Ω in transvenous systems ... a 12-V test pulse using the programmer command. Patients feel this pulse and may perceive it to be uncomfortable.

Defibrillator technology has advanced recently in a number of ways, such as the use of wireless connectivity, remote patient monitoring, and the development of quadripolar lead devices to enhance ...